RESUMO
Factor XI (FXI), a disulfide-linked covalent homodimer, circulates in plasma, and upon activation initiates the intrinsic/consolidation phase of coagulation. We present evidence that disulfide bonds in FXI are reduced to free thiols by oxidoreductases thioredoxin-1 (TRX-1) and protein disulfide isomerase (PDI). We identified that Cys362-Cys482 and Cys118-Cys147 disulfide bonds are reduced by TRX-1. The activation of TRX-1-treated FXI by thrombin, FXIIa or FXIa was significantly increased compared to non-reduced FXI, indicating that the reduced factor is more efficiently activated than the oxidized protein. Using a novel ELISA system, we compared the amount of reduced FXI in antiphospholipid syndrome (APS) thrombosis patients with levels in healthy controls, and found that APS patients have higher levels of reduced FXI. This may have implication for understanding the contribution of FXI to APS thrombosis, and the predisposition to thrombosis in patients with elevated plasma levels of reduced FXI.
Assuntos
Síndrome Antifosfolipídica/sangue , Fator XI/agonistas , Isomerases de Dissulfetos de Proteínas/sangue , Tiorredoxinas/sangue , Trombose/sangue , Adulto , Idoso , Síndrome Antifosfolipídica/complicações , Síndrome Antifosfolipídica/enzimologia , Coagulação Sanguínea , Estudos de Casos e Controles , Cisteína/metabolismo , Dissulfetos/química , Ensaio de Imunoadsorção Enzimática , Fator XI/química , Fator XI/metabolismo , Fator XIIa/metabolismo , Fator XIIa/farmacologia , Fator XIa/metabolismo , Fator XIa/farmacologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Oxirredução , Tiorredoxinas/metabolismo , Tiorredoxinas/farmacologia , Trombina/metabolismo , Trombina/farmacologia , Trombose/complicações , Trombose/enzimologiaRESUMO
ß2-Glycoprotein I (ß2GPI) is an evolutionary conserved, abundant circulating protein. Although its function remains uncertain, accumulated evidence points toward interactions with endothelial cells and components of the coagulation system, suggesting a regulatory role in vascular biology. Our group has shown that thioredoxin 1 (TRX-1) generates free thiols in ß2GPI, a process that may have a regulatory role in platelet adhesion. This report extends these studies and shows for the first time evidence of ß2GPI with free thiols in vivo in both multiple human and murine serum samples. To explore how the vascular surface may modulate the redox status of ß2GPI, unstimulated human endothelial cells and EAhy926 cells are shown to be capable of amplifying the effect of free thiol generation within ß2GPI. Multiple oxidoreductase enzymes, such as endoplasmic reticulum protein 46 (ERp 46) and TRX-1 reductase, in addition to protein disulfide isomerase are secreted on the surface of endothelial cells. Furthermore, one or more of these generated free thiols within ß2GPI are also shown to be nitrosylated. Finally, the functional significance of these findings is explored, by showing that free thiol-containing ß2GPI has a powerful effect in protecting endothelial cells and EAhy926 cells from oxidative stress-induced cell death.